lung caner, lung infection, mediastinal tumor, pneumothorax
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who have undergone surgery for lung cancer, lung infection, mediastinal tumor, or pneumothorax at the Department of Oncology, Nagasaki University (ii) All open thoracic procedures (conventional thoracotomy, thoracoscopic surgery, robotic-assisted surgery) except for median sternotomy (iii) Patients who underwent respiratory surgery from the date of study approval to 3/31/2024 and who, despite receiving standard postoperative analgesics (loxoprofen 3 tablets 3/day + acetaminophen (500) 4 tablets 4/day from the day after surgery), had a maximum daily VAS (Visual analogue scale: 0 (no pain at all) to 10 (maximum imaginable pain) > 40 mm.
Exclusion criteria
Exclusion criteria: (1) Patients who underwent surgery through a median sternotomy (2) Patients who have been taking some kind of analgesic medication before the surgery (iii) Patients who have difficulty in transmitting sensation from TENS to the examiner (4) Patients with heart disease or pacemaker implants (5) Pregnant women or patients who may become pregnant (vi) Patients who are participating in clinical trials, other clinical studies, or observational studies (vii) Other patients who are deemed inappropriate as research subjects by the investigators, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute pain and TENS entrainment after thoracic surgery: If both pain and TENS stimulation are reduced or eliminated, the patient is entrained. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluating VAS trends in patients treated with TENS for acute pain in thoracic surgery | — |
Countries
Japan
Contacts
Nagasaki University Graduate School of Medicine Surgical Oncology